- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: doxorubicin hydrochloride
Total 8557 results
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI)Completed
-
InxMed (Shanghai) Co., Ltd.Recruiting
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Theodore LaetschWithdrawnSarcoma | Osteosarcoma | Sarcoma, Ewing | Neuroblastoma | Rhabdomyosarcoma | DesmoidUnited States
-
Duke UniversityNational Cancer Institute (NCI)Terminated
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer InstituteCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Children's Cancer and Leukaemia GroupSociete Francaise Oncologie PediatriqueUnknown
-
Kyoto UniversityTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
University of Tennessee Cancer InstituteGenentech, Inc.; Celgene Corporation; National Comprehensive Cancer NetworkUnknownBreast CancerUnited States
-
National Cancer Centre, SingaporeUnknown
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterOrtho Biotech, Inc.Completed
-
Northwestern UniversityAgenus Inc.; CarTheraRecruitingGlioblastoma Multiforme | Gliosarcoma | Newly Diagnosed Glioblastoma | Glioblastoma, Isocitric Dehydrogenase (IDH)-WildtypeUnited States
-
PfizerTerminatedOvarian Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
PharmaMarCompletedOvarian CancerUnited States
-
Grupo Español de Investigación en Cáncer de OvarioPharmaMarCompleted
-
University of Southern CaliforniaTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedCarcinoma | CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingNeuroendocrine Tumors | High Grade Neuroendocrine Carcinoma, Any Site | Well-Differentiated Neuroendocrine CarcinomaUnited States
-
AstraZenecaTerminatedSolid TumorsItaly, Switzerland
-
AGO Study GroupEssex Pharma GmbH; MedServ. GmbH, WiesbadenCompletedCervical Cancers | Cancer of the Ovary Treated as 2nd Line Therapy | Muellerian Mixed Tumours | Tumours of the Uterus | Non-Epithelial Ovarian TumoursGermany
-
SOTIO a.s.TerminatedEpithelial Ovarian CarcinomaGermany, Poland, Czech Republic
-
Galderma R&DCompleted
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownAdult Acute Lymphoblastic LeukemiaChina
-
Alaunos TherapeuticsUnknownSoft Tissue SarcomaUnited States, Italy, Romania
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Grupo Español de Investigación en Cáncer de OvarioNeovii BiotechCompleted
-
University Hospital, Strasbourg, FranceCompletedHepato Cellular CarcinomaFrance
-
Peking Union Medical College HospitalCompleted
-
Italian Sarcoma GroupCompleted
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
EndocyteTerminated
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
SCRI Development Innovations, LLCAventis Pharmaceuticals; Ortho Biotech, Inc.CompletedBreast CancerUnited States
-
TelikCompletedOvarian NeoplasmsUnited States
-
ARCAGY/ GINECO GROUPCompleted
-
University of California, San FranciscoWithdrawn
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Unresectable Hepatocellular CarcinomaUnited States
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
Children's National Research InstituteRecruitingSoft Tissue Sarcoma | Ewing Sarcoma | Bone Metastases | Solid Tumors | Rhabdomyosarcoma | Wilms Tumor | Germ Cell Tumor | Hepatic Tumor | Malignant Epithelial NeoplasmUnited States
-
Shattuck Labs, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal CarcinomaUnited States, United Kingdom, Spain, Canada
-
M.D. Anderson Cancer CenterWithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8